Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Aminoglycoside-induced nephrotoxicity]

V Fabrizii1, F Thalhammer, W H Hörl

  • 1Klinische Abteilung für Nephrologie und Dialyse, Klinik für Innere Medizin III, Universität Wien, Osterreich.

Wiener Klinische Wochenschrift
|February 7, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the impact of surveillance test strategies: a cost-benefit modelling analysis based upon real-world data from SARS-CoV-2.

Public health·2024
Same author

<i>In vivo</i> / <i>in vitro</i> Correlation of Pharmacokinetics of Gentamicin, Vancomycin, Teicoplanin and Doripenem in a Bovine Blood Hemodialysis Model.

Frontiers in pharmacology·2021
Same author

Sepsis caused by multidrug-resistant klebsiella pneumoniae infection in a 23-year-old burn patient: case report and literature review.

Annals of burns and fire disasters·2018
Same author

Elimination of Doripenem during Dialysis and Pharmacokinetic Evaluation of Posthemodialysis Dosing for Patients Undergoing Intermittent Renal Replacement Therapy.

Antimicrobial agents and chemotherapy·2018
Same author

Micafungin Plasma Levels Are Not Affected by Continuous Renal Replacement Therapy: Experience in Critically Ill Patients.

Antimicrobial agents and chemotherapy·2017
Same author

Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE).

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2016
Same journal

[Vaccination of immunocompromised individuals: Expert opinion - update 2026].

Wiener klinische Wochenschrift·2026
Same journal

Systematic review of clinical evidence for Kneipp medicine.

Wiener klinische Wochenschrift·2026
Same journal

Pelvic resections in primary sarcomas : Surgical outcomes and survival analysis of 75 patients.

Wiener klinische Wochenschrift·2026
Same journal

Jungmediziner*innen am Start: 11. Workshop für den medizinischen Nachwuchs.

Wiener klinische Wochenschrift·2026
Same journal

Stellungnahme der ÖGP zur geplanten Gesetzesnovelle zum Nichtraucherschutzgesetz.

Wiener klinische Wochenschrift·2026
Same journal

MUW researcher of the month: Dr. Moritz Schaefer.

Wiener klinische Wochenschrift·2026
See all related articles

Aminoglycosides are effective for gram-negative infections but can cause kidney damage. A single daily intravenous dose, combined with other measures, minimizes nephrotoxicity while maintaining efficacy.

Area of Science:

  • Pharmacology
  • Nephrology
  • Infectious Diseases

Context:

  • Aminoglycosides are crucial first-line antibiotics for severe gram-negative infections.
  • Nephrotoxicity and other side effects limit aminoglycoside use.
  • High peak levels are essential for efficacy, while prolonged trough levels increase toxicity risk.

Purpose:

  • To evaluate the efficacy and safety of a single daily intravenous aminoglycoside dosing regimen.
  • To identify strategies for minimizing aminoglycoside-induced nephrotoxicity.
  • To optimize aminoglycoside therapy for severe gram-negative infections.

Summary:

  • Single daily intravenous aminoglycoside administration achieves high antibacterial efficacy with reduced nephrotoxicity compared to other methods.
  • Nephrotoxicity primarily affects proximal tubule cells and is often reversible.

Related Experiment Videos

  • Implementing a single daily dose, adequate hydration, bicarbonate therapy, trough level monitoring, and short treatment duration (5 days) prevents renal impairment in most patients.

    • Impact:

    • Single daily dosing transforms aminoglycoside therapy, making acute renal failure an avoidable complication.
    • This regimen optimizes the benefit-risk ratio of aminoglycosides in clinical practice.
    • Improved patient outcomes and reduced healthcare burden associated with aminoglycoside-related toxicity.